SanBio Company Limited (TYO: 4592)
Japan
· Delayed Price · Currency is JPY 764.00
+46.00 (6.41%)
Dec 27, 2024, 3:45 PM JST
SanBio Company Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | - | - | 447 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -39.68% | Upgrade
|
| Gross Profit | - | - | - | - | - | 447 | Upgrade
|
| Selling, General & Admin | 1,228 | 1,690 | 1,781 | 1,665 | 1,730 | 1,606 | Upgrade
|
| Research & Development | 2,069 | 2,849 | 6,118 | 4,955 | 4,071 | 4,327 | Upgrade
|
| Operating Expenses | 3,297 | 4,539 | 7,899 | 6,620 | 5,801 | 5,933 | Upgrade
|
| Operating Income | -3,297 | -4,539 | -7,899 | -6,620 | -5,801 | -5,486 | Upgrade
|
| Interest Expense | -8.73 | -10 | -26 | -44 | -48 | -47 | Upgrade
|
| Interest & Investment Income | 2.19 | 2 | 4 | 5 | 8 | 15 | Upgrade
|
| Currency Exchange Gain (Loss) | 333.87 | 1,746 | 3,326 | 1,961 | -634 | -61 | Upgrade
|
| Other Non Operating Income (Expenses) | -17.47 | -23 | -103 | 119 | -54 | 432 | Upgrade
|
| EBT Excluding Unusual Items | -2,988 | -2,824 | -4,698 | -4,579 | -6,529 | -5,147 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 3,318 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 9.12 | 33 | 1 | - | - | - | Upgrade
|
| Asset Writedown | -0.04 | -3 | - | -10 | - | -9 | Upgrade
|
| Other Unusual Items | 180.98 | 252 | - | 29 | - | - | Upgrade
|
| Pretax Income | -2,797 | -2,542 | -4,697 | -4,560 | -3,211 | -5,156 | Upgrade
|
| Income Tax Expense | 116.19 | 102 | 862 | 117 | 174 | 1 | Upgrade
|
| Net Income | -2,914 | -2,644 | -5,559 | -4,677 | -3,385 | -5,157 | Upgrade
|
| Net Income to Common | -2,914 | -2,644 | -5,559 | -4,677 | -3,385 | -5,157 | Upgrade
|
| Shares Outstanding (Basic) | 68 | 65 | 58 | 52 | 52 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 65 | 58 | 52 | 52 | 51 | Upgrade
|
| Shares Change (YoY) | 5.87% | 12.78% | 11.83% | 0.01% | 1.31% | 5.31% | Upgrade
|
| EPS (Basic) | -42.82 | -40.48 | -95.98 | -90.31 | -65.37 | -100.89 | Upgrade
|
| EPS (Diluted) | -42.82 | -40.48 | -95.98 | -90.31 | -65.37 | -100.89 | Upgrade
|
| Free Cash Flow | - | -4,776 | -7,441 | -6,588 | -5,311 | -5,812 | Upgrade
|
| Free Cash Flow Per Share | - | -73.11 | -128.47 | -127.21 | -102.56 | -113.71 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -1227.29% | Upgrade
|
| Profit Margin | - | - | - | - | - | -1153.69% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -1300.22% | Upgrade
|
| EBITDA | -3,290 | -4,525 | -7,875 | -6,488 | -5,727 | -5,447 | Upgrade
|
| D&A For EBITDA | 6.92 | 14 | 24 | 132 | 74 | 39 | Upgrade
|
| EBIT | -3,297 | -4,539 | -7,899 | -6,620 | -5,801 | -5,486 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.